Welcome to our dedicated page for Barclays news (Ticker: BCS), a resource for investors and traders seeking the latest updates and insights on Barclays stock.
Barclays PLC (BCS) generates a steady flow of news across commercial banking, investment banking, capital markets and research. As a British universal bank with UK consumer, corporate, wealth and private banking franchises, a global investment bank and a specialist US consumer bank, its announcements span operational performance, capital actions and strategic developments.
On this page, readers can follow Barclays news related to share buy-backs, capital ratios, regulatory interactions and product actions. Recent Form 6-K filings and press releases have covered topics such as the Bank of England’s 2025 bank capital stress test results, where Barclays was assessed as sufficiently capitalised under the stress scenario, and multi-stage share repurchase programmes aimed at reducing share capital by cancelling repurchased ordinary shares.
Barclays news also reflects its role in investment banking and capital markets. Press releases in 2025 highlight senior appointments in mergers and acquisitions, capital markets and investment banking leadership, along with references to external rankings for M&A advisory and debt capital markets activity. Additional announcements describe cash tender offers, consent solicitations and redemptions for iPath-branded exchange-traded notes, including detailed risk disclosures for ETN investors.
Another important stream of news comes from Barclays Research, which publishes thematic work on artificial intelligence, humanoid robotics, labour markets, energy and global supply chains. These releases summarise key findings from the Equity Gilt Study and Impact Series reports, offering long-term perspectives on structural changes affecting markets and economies.
Investors and followers of BCS stock can use this news feed to monitor regulatory filings, capital management decisions, structured product actions, leadership changes and research publications that shape the bank’s strategic direction and risk profile over time.
Barclays Bank PLC announced that it will redeem all outstanding iPath® Bloomberg Natural Gas Subindex Total Return ETNs on October 29, 2021. The decision follows a cash tender offer and consent solicitation that allowed Barclays to amend the ETNs' indenture, granting the right to redeem at its discretion. Holders of the ETNs will receive a cash payment based on the principal amount multiplied by the Index Factor on the Valuation Date, minus the Investor Fee. The ETNs are subject to significant risks, including lack of principal protection and potential loss of value.
Barclays Bank PLC has completed a cash tender offer for its iPath® Bloomberg Natural Gas Subindex Total Return ETNs due October 22, 2037. The offer, which expired on October 14, 2021, resulted in the acceptance of 3,764,993 Notes, representing 52.37% of the total outstanding. The purchase price was set at $0.15 per Note, totaling $564,748.95. Additionally, Barclays has secured the necessary consents for a proposed amendment allowing it to redeem all outstanding Notes at its discretion. The settlement date for this transaction is October 18, 2021.
Barclays Bank PLC has confirmed that there will be no changes to the constituents in the CIBC Atlas Select MLP Index during the quarterly rebalancing starting after October 8, 2021. The iPath Select MLP ETNs, linked to this Index, are traded on the CBOE BZX Exchange under the ticker symbol ATMP. Investors should be aware of the significant risks associated with these ETNs, including potential loss of principal, high volatility, and the absence of guaranteed coupon payments. The Index comprises 20 constituents from the Energy Sector, and its rebalancing methodology is based on credit ratings and trading volumes.
Barclays has appointed Gabriel Casillas as the new Chief Economist for Latin America, focusing on economic research and the Mexican economy from New York. Mr. Casillas, who has over 15 years of industry experience, previously served at Grupo Financiero Banorte as Chief Economist and Head of Investor Relations and ESG. He has held positions at J.P. Morgan and UBS, specializing in Mexico and Chile. His appointment reflects Barclays' commitment to enhancing its economic insights and capabilities.
Barclays Bank PLC has extended the expiration deadline for its cash tender offer to purchase iPath Bloomberg Natural Gas Subindex Total Return ETNs, now ending on October 14, 2021. The Purchase Price has increased by 50% from $0.10 to $0.15 per Note tendered. Noteholders who've already submitted tenders do not need to act again to benefit from the new price. As of September 29, 2021, 3,322,577 Notes, or 46.22% of outstanding Notes, have been tendered. The Offer is subject to market fluctuations, which may affect Note values significantly.
Barclays has appointed Naeem Merchant as Managing Director in Healthcare Investment Banking, effective October 2021. Based in New York, he will focus on the Pharmaceutical Services and IT sectors while reporting to Rick Landgarten. Mr. Merchant brings over 14 years of experience from Greenhill & Co. and Lehman Brothers, where he executed high-profile transactions. His addition is seen as a strategic move to enhance Barclays' Healthcare franchise, which has recently engaged in significant deals, including a $21bn acquisition by Thermo Fisher Scientific.
Barclays has appointed Amit Tyagi as a Managing Director in Healthcare Investment Banking, based in New York. With over 20 years of experience, Tyagi previously served as Head of Healthcare at Huatai Securities and Global Head of Medical Diagnostics and Life Sciences Tools at UBS. This appointment is expected to enhance Barclays' capabilities in the Tools and Diagnostics sector. The bank has been involved in significant transactions, including advising on $21 billion acquisition of PPD by Thermo Fisher Scientific and $3.4 billion sale of HMS to Gainwell Technologies.
Barclays Bank PLC announced it will not extend its Exchange Offer for iPath S&P GSCI Crude Oil Total Return Index ETNs due August 14, 2036. The Exchange Offer ended on August 31, 2021, with 92,211 Old Notes accepted, representing 18.33% of the total. The company also revealed preliminary results for the Tender Offer, where 40,891 Old Notes were accepted, equating to 8.13% of the outstanding notes. The expected total purchase price for these notes is approximately $5.05 million. Barclays anticipates not obtaining the necessary consents for proposed amendments in the Consent Solicitation.
Barclays Bank PLC has established a purchase price of $123.5398 for its cash tender offer to buy back its iPath® S&P GSCI® Crude Oil Total Return Index ETNs, due August 14, 2036. This price marks a 5% premium over the Closing Indicative Note Value of $117.6570 as of August 31, 2021. The tender offer and related consent solicitation expire at 11:59 p.m. New York City time on August 31, 2021, unless extended. Noteholders can opt for either a tender or an exchange offer for new ETNs, but simultaneous tenders are invalid.
Barclays Bank PLC has extended the expiration deadlines for its Exchange Offer and Cash Tender Offer concerning the iPath® S&P GSCI® Crude Oil ETNs. The Exchange Offer now expires on August 31, 2021, offering a 5.68% premium and an exchange ratio of six New Notes for each Old Note. The Cash Tender Offer sets a 105% purchase price based on the closing indicative note value as of the expiration date. Noteholders have tendered 67,611 Old Notes across both offers. The update emphasizes potential price fluctuations linked to the S&P GSCI Index performance.